These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7481765)

  • 1. Aberrant subcellular localization of BRCA1 in breast cancer.
    Chen Y; Chen CF; Riley DJ; Allred DC; Chen PL; Von Hoff D; Osborne CK; Lee WH
    Science; 1995 Nov; 270(5237):789-91. PubMed ID: 7481765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location of BRCA1 in human breast and ovarian cancer cells.
    Scully R; Ganesan S; Brown M; De Caprio JA; Cannistra SA; Feunteun J; Schnitt S; Livingston DM
    Science; 1996 Apr; 272(5258):123-6. PubMed ID: 8600523
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations of the BRCA1 gene in human cancer.
    Xu CF; Solomon E
    Semin Cancer Biol; 1996 Feb; 7(1):33-40. PubMed ID: 8695765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 mutations in primary breast and ovarian carcinomas.
    Futreal PA; Liu Q; Shattuck-Eidens D; Cochran C; Harshman K; Tavtigian S; Bennett LM; Haugen-Strano A; Swensen J; Miki Y
    Science; 1994 Oct; 266(5182):120-2. PubMed ID: 7939630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.
    Wilson CA; Ramos L; Villaseñor MR; Anders KH; Press MF; Clarke K; Karlan B; Chen JJ; Scully R; Livingston D; Zuch RH; Kanter MH; Cohen S; Calzone FJ; Slamon DJ
    Nat Genet; 1999 Feb; 21(2):236-40. PubMed ID: 9988281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1.
    Thomas JE; Smith M; Rubinfeld B; Gutowski M; Beckmann RP; Polakis P
    J Biol Chem; 1996 Nov; 271(45):28630-5. PubMed ID: 8910495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues.
    Neufing PJ; Kalionis B; Horsfall DJ; Ricciardelli C; Stahl J; Vivekanandan S; Raymond W; Tilley WD
    Anticancer Res; 2003; 23(2B):1479-88. PubMed ID: 12820413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the BRCA1 gene in ovarian cancers.
    Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA
    Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PML protein expression in hereditary and sporadic breast cancer.
    Plevová P; Bouchal J; Fiurásková M; Foretová L; Navrátilová M; Zapletalová J; Curík R; Kubala O; Prokop J; Kolár Z
    Neoplasma; 2007; 54(4):263-8. PubMed ID: 17822314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line.
    Aprelikova O; Kuthiala A; Bessho M; Ethier S; Liu ET
    Oncogene; 1996 Dec; 13(11):2487-91. PubMed ID: 8957093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer genes: therapeutic strategies.
    Holt JT
    Ann N Y Acad Sci; 1997 Dec; 833():34-41. PubMed ID: 9616738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
    Teng DH; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha PC; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick MH; Tavtigian SV; Jhanwar S; Swedlund B; Wong AK; Kamb A
    Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth retardation and tumour inhibition by BRCA1.
    Holt JT; Thompson ME; Szabo C; Robinson-Benion C; Arteaga CL; King MC; Jensen RA
    Nat Genet; 1996 Mar; 12(3):298-302. PubMed ID: 8589721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calretinin immunostaining in benign and malignant pleural effusions.
    Simsir A; Fetsch P; Abati A
    Diagn Cytopathol; 2001 Feb; 24(2):149-52. PubMed ID: 11169899
    [No Abstract]   [Full Text] [Related]  

  • 16. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
    Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
    Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
    Arason A; Jonasdottir A; Barkardottir RB; Bergthorsson JT; Teare MD; Easton DF; Egilsson V
    J Med Genet; 1998 Jun; 35(6):446-9. PubMed ID: 9643283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.
    Simard J; Tonin P; Durocher F; Morgan K; Rommens J; Gingras S; Samson C; Leblanc JF; Bélanger C; Dion F
    Nat Genet; 1994 Dec; 8(4):392-8. PubMed ID: 7894492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
    Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited breast and ovarian cancer.
    Szabo CI; King MC
    Hum Mol Genet; 1995; 4 Spec No():1811-7. PubMed ID: 8541881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.